Table 1

Clinical characteristics of patients in the derivation and validation cohorts

Derivation cohortValidation cohort
NSTE-TS
(n=100)
NSTEMI
(n=100)
P valueNSTE-TS
(n=40)
NSTEMI
(n=70)
P value
Age (years), mean±SD63.6±11.362.1±12.20.3661.1±12.062.6±12.50.55
Hypertension42 (42.0)57 (57.0)0.0313 (32.5)21 (30.0)0.78
Dyslipidaemia36 (36.0)42 (42.0)0.3810 (25.0)26 (37.1)0.19
Diabetes12 (12.0)31 (31.0)0.001112 (30.0)29 (41.4)0.23
Current smoker13 (13.0)19 (19.0)0.515 (12.5)17 (24.3)0.14
Stress70 (70.0)15 (15.0)<0.000126 (65.0)9 (12.9)<0.0001
Prior CVD4 (4.0)29 (29.0)<0.00013 (7.5)27 (38.6)0.0004
ST depression in any lead on admission1 (1.0)20 (20.0)<0.00016 (15)23 (32.9)<0.0001
ST depression in any lead on day 1 post-admission2 (2.0)11 (11.0)0.011 (2.5)24 (34.3)<0.0001
TWI >6 leads on admission14 (14.0)0 (0)0.00016 (15)8 (11)0.0005
TWI >6 leads on day 1 post-admission57 (57.0)10 (10.0)<0.000127 (67.5)14 (20)<0.0001
  • Values are n (%) unless otherwise stated.

  • CVD, cardiovascular disease; NSTEMI, non-ST segment elevation myocardial infarction; NSTE-TS, takotsubo syndrome with non-ST-segment elevation; TWI, T-wave inversion.